REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Alphamab Oncology (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alphamab Oncology Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Alphamab Oncology is a company focused on the development, manufacture and commercialization of innovative tumor immunobiomolecular targeting drugs in the entire industry chain. The company has built an anti-tumor product pipeline, of which four new drugs have entered the Phase I-III clinical trial development phase. It was founded in 2015, and headquartered in Suzhou City, China.

Headquarters
No. 175 Fangzhou Road, Suzhou Industrial Park, Suzhou
Suzhou; Jiangsu;

Contact Details: Purchase the Alphamab Oncology report to view the information.

Website: http://www.alphamabonc.com

Basic Information
Total Employees:
Purchase the Alphamab Oncology report to view the information.
Outstanding Shares:
Purchase the Alphamab Oncology report to view the information.
Registered Capital:
Purchase the Alphamab Oncology report to view the information.
Financial Auditors:
Purchase the Alphamab Oncology report to view the information.
Incorporation Date:
2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
33.43%
Purchase this report to view the information.
9.13%
Purchase this report to view the information.
9.13%
Purchase this report to view the information.
5.26%
Purchase this report to view the information.
0.03%
Subsidiaries
Alphamab Oncology (Bvi) Ltd. (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Alphamab Oncology report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
27.18%▲
Total operating revenue
29.14%▲
Operating profit (EBIT)
35.58%▲
EBITDA
54.41%▲
Net Profit (Loss) for the Period
-12.63%▼
Total assets
-8%▼
Total equity
-11.81%▼
Operating Profit Margin (ROS)
43.21%▲
Net Profit Margin
3.34%▲
Return on Equity (ROE)
-0.6%▼
Debt to Equity Ratio
4.52%▲
Quick Ratio
-1.93%▼
Cash Ratio
-1.05%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo